CNSPHARM KOREA Co., LTD.

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• DIRSEXMPT1 refused line

  DIRSEXMPT

• DRUG NAME1 refused line

  DRUG NAME

• LACKS N/C1 refused line

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• LIST INGRE1 refused line

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• UNAPPROVED1 refused line

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• UNSAFE COL1 refused line

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• USUAL NAME1 refused line

  Common or usual name missing

  The label appeared not to show the common or usual name of the food.

Questions about CNSPHARM KOREA Co., LTD.

Is CNSPHARM KOREA Co., LTD. on an FDA import alert?

No listing for CNSPHARM KOREA Co., LTD. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the South Korea page.

Has FDA refused shipments from CNSPHARM KOREA Co., LTD.?

Yes. FDA refused 1 shipment line from CNSPHARM KOREA Co., LTD. on March 1, 2021. The most recent, on March 1, 2021, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as LIST INGRE (ingredients not listed).

Why did FDA refuse CNSPHARM KOREA Co., LTD.'s shipments?

The most frequent charges are DIRSEXMPT (dirsexmpt, 1 line) and DRUG NAME (drug name, 1 line).

When was CNSPHARM KOREA Co., LTD. last inspected by FDA?

FDA's most recent inspection of CNSPHARM KOREA Co., LTD. with a final classification is dated May 24, 2016 and was classified NAI (No Action Indicated).

What is CNSPHARM KOREA Co., LTD.'s FEI number?

CNSPHARM KOREA Co., LTD.'s FDA Establishment Identifier (FEI) is 3010951939.